Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ningbo
Clinical trial register · China

Clinical Trials in Ningbo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 64 Guangzhou 47 Chengdu 45 Changsha 37 Chongqing 29
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
First Affiliated Hospital of Ningbo University20 Second Affiliated Hospital, Zhejiang University, School of Medicine15 Ningbo Medical Center Lihuili Hospital10 Ningbo No. 1 Hospital8 Janssen Research & Development, LLC6 Zhejiang Cancer Hospital5 Sanofi4 Yu jiren4 First Affiliated Hospital of Zhejiang University4 Ningbo No.2 Hospital3 The Affiliated People's Hospital of Ningbo University3 AstraZeneca3 Eli Lilly and Company3 Hoffmann-La Roche3 Changhai Hospital3 Novartis Pharmaceuticals3 Ningbo University3 Boehringer Ingelheim2 Women's Hospital School Of Medicine Zhejiang University2 Fudan University2 Peking Union Medical College Hospital2 Sir Run Run Shaw Hospital2 Pfizer2 Shanghai Jiao Tong University School of Medicine2 Abbott Medical Devices2 Ningbo Eye Hospital1 Peking University People's Hospital1 Cascade Pharmaceuticals, Inc1 Sino Medical Sciences Technology Inc.1 The First Affiliated Hospital with Nanjing Medical University1 Mao Jianhua1 Shanghai Pulmonary Hospital, Shanghai, China1 The Children's Hospital of Zhejiang University School of Medicine1 Zhejiang Provincial Center for Disease Control and Prevention1 Stryker Neurovascular1 Peking University1 Shanghai Mental Health Center1 Shanghai Tong Ren Hospital1 Shanghai Changzheng Hospital1 Shanghai Chest Hospital1 Liaoning Chengda Biotechnology CO., LTD1 Merck Sharp & Dohme LLC1 Lixia Sheng1 Beijing Tiantan Hospital1 Yifan Guo1 First Affiliated Hospital of Wenzhou Medical University1 The First Affiliated Hospital of Dalian Medical University1 Akeso1 Shanghai MicroPort EP MedTech Co., Ltd.1 Second Affiliated Hospital of Wenzhou Medical University1 Anhui Provincial Hospital1 Beijing Airdoc Technology Co., Ltd.1 Axter Therapeutics (Beijing) Co., Ltd1 Zhejiang Provincial People's Hospital1 Aragon Pharmaceuticals, Inc.1 Zhejiang University1 Beijing Sungen Biomedical Technology Co., Ltd1 argenx1 Hecheng Li M.D., Ph.D1 Kaikai QIU1 Shanghai 10th People's Hospital1 Clear sponsor filter
Site location
Beijing64 Guangzhou47 Chengdu45 Changsha37 Chongqing29 Shanghai25 Hefei25 Changchun25 Hangzhou24 Jinan24 Harbin21 Luoyang Shi14 Changzhou12 Tianjin12 Fuzhou10 Changde10 Nanjing10 Wuhan8 Nanchang8 Haikou6 Huzhou6 Foshan5 Luoyang5 Bengbu5 Suzhou5 Xiamen4 Wuhu4 Shenzhen4 Wenzhou4 Huizhou4 Lanzhou3 Anyang3 Minhang District3 Nanning3 Ningbo3 Zhengzhou3 Guangdong3 Xi'an3 Baotou3 Lishui3 Shijiazhuang3 Binzhou3 Guiyang2 Deyang2 Fuzhou Fujian2 Jiangmen2 Chaohu2 Haidian District2 Cheng Du Shi2 Hengyang2 Meihekou2 Kunming2 Chifeng1 Tainan1 Taipei1 Taoyuan1 Dalian1 Zhanjiang1 Zhongshan1 Jingzhou1 Linhai1 Taizhou1 Jiangyin1 Pingxiang1 Baoding1 Linfen1 Daqing1 Liaoyou1 Qingdao1 Shenyang1 Zhumadian1 Qinhuangdao Shi1 Changping1 Hengshui Shi1 Xuzhou1
All 75 locations
Target enrolment
to

Trials with a site in Ningbo

3 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Eli Lilly and Company
Phase 3
1,000
Changchun, Jinan, Luoyang Shi, Nanjing, Ningbo, Shijiazhuang, Tianjin
2026-10-16
Recruiting
Eli Lilly and Company
Phase 3
2,001
Chengdu, Hefei, Jinan, Luoyang Shi, Nanjing, Ningbo, Qinhuangdao Shi, Tianjin
2026-08-26
Recruiting
Eli Lilly and Company
Phase 2
222
Beijing, Chengdu, Chongqing, Hangzhou, Linhai, Ningbo, Shenzhen
2025-11-03
Rows per page Showing 1–3 of 3
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/ningbo

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3 of those studies with a site in Ningbo that also match the filters currently applied.

How many clinical trials are recruiting in Ningbo?

3 of the 3 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ningbo), 3 studies
PhaseStudiesRecruitingShare
Phase 32266.7%
Phase 21133.3%

Most active sponsors

Lead sponsors with the most studies (Ningbo)
Lead sponsorStudiesRecruiting
Eli Lilly and Company33
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.